文献速递血脂与心血管预防

对临床医生、患者或两者进行助推以增加他汀处方的整群随机临床试验

Effect of Nudges to Clinicians, Patients, or Both to Increase Statin Prescribing: A Cluster Randomized Clinical Trial.
PubMed 文献 · JAMA Cardiol · 2023-01-01

该整群随机临床试验纳入28个初级保健机构的158名临床医生和4131名患者,评估对临床医生、患者或两者进行助推是否增加就诊时他汀处方启动。结果显示,临床医生助推单独或联合患者助推均显著增加他汀处方,而患者助推单独无效。

核心结论

  • 对临床医生进行助推(无论是否联合患者助推)可显著增加初级保健就诊期间他汀处方的启动。
  • 单独对患者进行助推无效。

研究设计与样本

  • 整群随机临床试验,纳入28个初级保健机构的158名临床医生和4131名患者,包括12个月干预期前和6个月干预期(2019年10月19日至2021年4月18日)。

主要发现

  • 干预期间他汀处方率:常规护理组7.3%(75/1032),患者助推组8.5%(100/1181),临床医生助推组13.0%(128/981),联合助推组15.5%(145/937)。

关键数值与推荐

  • 临床医生助推包括电子健康记录中的主动选择提示和每月处方模式同行反馈。
  • 患者助推为就诊前4天发送的交互式短信。

临床怎么用

  • 在初级保健中,可优先采用临床医生助推(如电子健康记录提示和反馈)来促进他汀处方启动。
  • 单独患者助推策略效果有限,建议与临床医生助推联合使用。

局限性

  • 研究仅涉及初级保健机构,结论外推需谨慎。
  • 干预期间较短(6个月),长期效果未评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Statins reduce the risk of major adverse cardiovascular events, but less than one-half of individuals in America who meet guideline criteria for a statin are actively prescribed this medication. OBJECTIVE: To evaluate whether nudges to clinicians, patients, or both increase initiation of statin prescribing during primary care visits. DESIGN, SETTING, AND PARTICIPANTS: This cluster randomized clinical trial evaluated statin prescribing of 158 clinicians from 28 primary care practices including 4131 patients. The design included a 12-month preintervention period and a 6-month intervention period between October 19, 2019, and April 18, 2021. INTERVENTIONS: The usual care group received no interventions. The clinician nudge combined an active choice prompt in the electronic health record during the patient visit and monthly feedback on prescribing patterns compared with peers. The patient nudge was an interactive text message delivered 4 days before the visit. The combined nudge included the clinician and patient nudges. MAIN OUTCOMES AND MEASURES: The primary outcome was initiation of a statin prescription during the visit. RESULTS: The sample comprised 4131 patients with a mean (SD) age of 65.5 (10.5) years; 2120 (51.3%) were male; 1210 (29.3%) were Black, 106 (2.6%) were Hispanic, 2732 (66.1%) were White, and 83 (2.0%) were of other race or ethnicity, and 933 (22.6%) had atherosclerotic cardiovascular disease. In unadjusted analyses during the preintervention period, statins were prescribed to 5.6% of patients (105 of 1876) in the usual care group, 4.8% (97 of 2022) in the patient nudge group, 6.0% (104 of 1723) in the clinician nudge group, and 4.7% (82 of 1752) in the combined group. During the intervention, statins were prescribed to 7.3% of patients (75 of 1032) in the usual care group, 8.5% (100 of 1181) in the patient nudge group, 13.0% (128 of 981) in the clinician nudge arm, and 15.5% (145 of 937) in the combined group. In the main adjusted analyses relative to usual care, the clinician nudge significantly increased statin prescribing alone (5.5 percentage points; 95% CI, 3.4 to 7.8 percentage points; P = .01) and when combined with the patient nudge (7.2 percentage points; 95% CI, 5.1 to 9.1 percentage points; P = .001). The patient nudge alone did not change statin prescribing relative to usual care (0.9 percentage points; 95% CI, -0.8 to 2.5 percentage points; P = .32). CONCLUSIONS AND RELEVANCE: Nudges to clinicians with and without a patient nudge significantly increased initiation of a statin prescription during primary care visits. The patient nudge alone was not effective. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT04307472.

来源:JAMA Cardiol,查看原文。版权归原作者所有。

引用

  1. Adusumalli S, Kanter GP, Small DS, et al. Effect of Nudges to Clinicians, Patients, or Both to Increase Statin Prescribing: A Cluster Randomized Clinical Trial. JAMA Cardiol. 2023. PMID: 36449275. doi:10.1001/jamacardio.2022.4373

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。